4 results  1 of 1 

1 Effect of Afatinib for Lung Cancer on Papillary Thyroid Carcinoma
Sang Hwon Cho, Jin Seok Lee, Hyeok Jun Yun, Yong Sang Lee, Hang-Seok Chang
Int J Thyroidol.2022;15(2):131-134.   Published online 2022 November 30     DOI: http://dx.doi.org/10.11106/ijt.2022.15.2.131
      
2 Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M Grabowska, David O. Bates, Kanokpan Wongprasert
Cancer Res Treat.2021;53(2):457-470.   Published online 2020 October 7     DOI: http://dx.doi.org/10.4143/crt.2020.585
      
3 Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Youjin Kim, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jong-Mu Sun
Cancer Res Treat.2019;51(2):502-509.   Published online 2018 June 13     DOI: http://dx.doi.org/10.4143/crt.2018.117
      
4 Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report
Cheol Kyu Park, Jae Young Hur, Chang-Min Choi, Tae-Ok Kim, Hyun-Ju Cho, Hong-Joon Shin, Jung-Hwan Lim, Yoo-Duk Choi, Young-Chul Kim, In-Jae Oh
J Korean Med Sci.2018;33(1):e7.  Published online 2017 November 10     DOI: http://dx.doi.org/10.3346/jkms.2018.33.e7
      

 1 of 1